Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma

Nanoscale

Volumn 7, Issue 21, 2015, Pages 9487-9496

  Ruan, Shaobo ^a   He, Qin ^a   Gao, Huile ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; ENZYME ACTIVITY; GOLD; MOBILE SECURITY; NANOPARTICLES;

GELATIN NANOPARTICLES; GOLD NANOPARTICLE; MATRIX METALLOPROTEINASE-2; MATRIX METALLOPROTEINASES; PENETRATION ABILITY; TARGETING DELIVERIES; TREATMENT OUTCOMES; TUMOR MICROENVIRONMENT;

TUMORS;

CARBOCYANINE; CY5.5 CYANINE DYE; DOXORUBICIN; DRUG CARRIER; GELATIN; GELATINASE A; GOLD; METAL NANOPARTICLE;

ANIMAL; BRAIN; BRAIN NEOPLASMS; CHEMISTRY; GLIOMA; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PARTICLE SIZE; PATHOLOGY; PH; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; XENOGRAFT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; GELATIN; GLIOMA; GOLD; HUMANS; HYDROGEN-ION CONCENTRATION; MATRIX METALLOPROTEINASE 2; METAL NANOPARTICLES; MICE; MICE, NUDE; PARTICLE SIZE; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 84930074441     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c5nr01408e     Document Type: Article

References (43)

1. K. Park The Controlled Drug Delivery Systems: Past Forward and Future Back J. Controlled Release 2014 190 3 8
2. Y. C. Barenholz Doxil(R) - The first FDA-approved nano-drug: Lessons learned J. Controlled Release 2012 160 117 134
3. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005 5 161 171
4. Y. H. Bae K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Controlled Release 2011 153 198 205
5. J. Fang H. Nakamura H. Maeda The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Delivery Rev. 2011 63 136 151
6. N. Bertrand J. Wu X. Xu N. Kamaly O. C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Delivery Rev. 2014 66 2 25
7. J. S. Lee M. Ankone E. Pieters R. M. Schiffelers W. E. Hennink J. Feijen Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes J. Controlled Release 2011 155 282 288
8. S. D. Li L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 2008 5 496 504
9. H. Cabral Y. Matsumoto K. Mizuno Q. Chen M. Murakami M. Kimura Y. Terada M. R. Kano K. Miyazono M. Uesaka N. Nishiyama K. Kataoka Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 2011 6 815 823
10. S. D. Perrault C. Walkey T. Jennings H. C. Fischer W. C. Chan Mediating tumor targeting efficiency of nanoparticles through design Nano Lett. 2009 9 1909 1915
11. G. Kibria H. Hatakeyama N. Ohga K. Hida H. Harashima The effect of liposomal size on the targeted delivery of doxorubicin to Integrin alphavbeta3-expressing tumor endothelial cells Biomaterials 2013 34 5617 5627
12. P. A. Forsyth H. Wong T. D. Laing N. B. Rewcastle D. G. Morris H. Muzik K. J. Leco R. N. Johnston P. M. Brasher G. Sutherland D. R. Edwards Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br. J. Cancer 1999 79 1828 1835
13. C. Wong T. Stylianopoulos J. Cui J. Martin V. P. Chauhan W. Jiang Z. Popovic R. K. Jain M. G. Bawendi D. Fukumura Multistage nanoparticle delivery system for deep penetration into tumor tissue Proc. Natl. Acad. Sci. U. S. A. 2011 108 2426 2431
14. H. Gao Z. Pang X. Jiang Targeted delivery of nano-therapeutics for major disorders of the central nervous system Pharm. Res. 2013 30 2485 2498
15. S. Ruan M. Yuan L. Zhang G. Hu J. Chen X. Cun Q. Zhang Y. Yang Q. He H. Gao Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles Biomaterials 2015 37 425 435
16. Y. Liu R. Ran J. Chen Q. Kuang J. Tang L. Mei Q. Zhang H. Gao Z. Zhang Q. He Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting Biomaterials 2014 35 4835 4847
17. C. Zhan B. Gu C. Xie J. Li Y. Liu W. Lu Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect J. Controlled Release 2010 143 136 142
18. L. Bello M. Francolini P. Marthyn J. Zhang R. S. Carroll D. C. Nikas J. F. Strasser R. Villani D. A. Cheresh P. M. Black Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery Neurosurgery 2001 49 380-389 390
19. Y. Adachi S. S. Lakka N. Chandrasekar N. Yanamandra C. S. Gondi S. Mohanam D. H. Dinh W. C. Olivero M. Gujrati T. Tamiya T. Ohmoto G. Kouraklis B. Aggarwal J. S. Rao Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes J. Biol. Chem. 2001 276 47171 47177
20. H. Gao Q. Zhang Z. Yu Q. He Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery Curr. Pharm. Biotechnol. 2014 15 210 219
21. C. Ansari G. A. Tikhomirov S. H. Hong R. A. Falconer P. M. Loadman J. H. Gill R. Castaneda F. K. Hazard L. Tong O. D. Lenkov D. W. Felsher J. Rao H. E. Daldrup-Link Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy Small 2014 10 566-575 417
22. M. A. Stuart W. T. Huck J. Genzer M. Muller C. Ober M. Stamm G. B. Sukhorukov I. Szleifer V. V. Tsukruk M. Urban F. Winnik S. Zauscher I. Luzinov S. Minko Emerging applications of stimuli-responsive polymer materials Nat. Mater. 2010 9 101 113
23. S. Ganta H. Devalapally A. Shahiwala M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Controlled Release 2008 126 187 204
24. F. Q. Hu Y. Y. Zhang J. You H. Yuan D. YZ pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy Mol. Pharm. 2012 9 2469 2478
25. X. He J. Li S. An C. Jiang pH-sensitive drug-delivery systems for tumor targeting Ther. Delivery 2013 4 1499 1510
26. L. E. Gerweck K. Seetharaman Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res. 1996 56 1194 1198
27. J. Li Y. Zhou C. Li D. Wang Y. Gao C. Zhang L. Zhao Y. Li Y. Liu X. Li Poly(2-ethyl-2-oxazoline)-Doxorubicin Conjugate-Based Dual Endosomal pH-Sensitive Micelles with Enhanced Antitumor Efficacy Bioconjugate Chem. 2015 26 110 119
28. C. Ziegler A. Eychmüller Seeded Growth Synthesis of Uniform Gold Nanoparticles with Diameters of 15-300 nm J. Phys. Chem. C 2011 115 4502 4506
29. H. Gao Z. Yang S. Zhang Z. Pang Q. Liu X. Jiang Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays Acta Biomater. 2014 10 858 867
30. H. Gao Z. Yang S. Cao Y. Xiong S. Zhang Z. Pang X. Jiang Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment Biomaterials 2014 35 2374 2382
31. H. Gao Y. Xiong S. Zhang Z. Yang S. Cao X. Jiang RGD and Interleukin-13 Peptide Functionalized Nanoparticles for Enhanced Glioblastoma Cells and Neovasculature Dual Targeting Delivery and Elevated Tumor Penetration Mol. Pharm. 2014 11 1042 1052
32. H. Lee K. Lee I. K. Kim T. G. Park Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes Biomaterials 2008 29 4709 4718
33. C. C. Lee A. T. Cramer F. J. Szoka J. M. Frechet An intramolecular cyclization reaction is responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin Bioconjugate Chem. 2006 17 1364 1368
34. R. K. Jain Delivery of molecular and cellular medicine to solid tumors Adv. Drug Delivery Rev. 2001 46 149 168
35. Y. Liu M. Ji M. K. Wong K. I. Joo P. Wang Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery BioMed. Res. Int. 2013 2013 378380
36. H. Gao Z. Yang S. Zhang Z. Pang X. Jiang Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles J. Drug Targeting 2014 22 450 459
37. K. M. McMahon M. Volpato H. Y. Chi P. Musiwaro K. Poterlowicz Y. Peng A. J. Scally L. H. Patterson R. M. Phillips C. W. Sutton Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids J. Proteome Res. 2012 11 2863 2875
38. J. Ou W. Luan J. Deng R. Sa H. Liang alphaV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway PLoS One 2012 7 e38737
39. Z. Popovic W. Liu V. P. Chauhan J. Lee C. Wong A. B. Greytak N. Insin D. G. Nocera D. Fukumura R. K. Jain M. G. Bawendi A nanoparticle size series for in vivo fluorescence imaging Angew. Chem., Int. Ed. 2010 49 8649 8652
40. H. Gao J. Qian S. Cao Z. Yang Z. Pang S. Pan L. Fan Z. Xi X. Jiang Q. Zhang Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles Biomaterials 2012 33 5115 5123
41. D. J. Burkhart B. T. Kalet M. P. Coleman G. C. Post T. H. Koch Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin Mol. Cancer Ther. 2004 3 1593 1604
42. R. Tong H. H. Chiang D. S. Kohane Photoswitchable nanoparticles for in vivo cancer chemotherapy Proc. Natl. Acad. Sci. U. S. A. 2013 110 19048 19053
43. R. Liu D. Li B. He X. Xu M. Sheng Y. Lai G. Wang Z. Gu Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles J. Controlled Release 2011 152 49 56